University licenses technology for coronavirus and norovirus compounds
Posted on February 28, 2020
Amid increasing worldwide concern about a novel coronavirus, COVID-19, Kansas State University has licensed a technology that may lead to the production of an antiviral drug to treat coronaviruses and noroviruses.